The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
7-((5-chloro-3-(trifluoromethyl)-1H-pyrazol-1-yl)methyl)-2-methyl-3-(pyrimidin-5-yl)-5H-thiazolo[3,2-a]pyrimidin-5-one ID: ALA3985768
PubChem CID: 118017811
Max Phase: Preclinical
Molecular Formula: C16H10ClF3N6OS
Molecular Weight: 426.81
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1sc2nc(Cn3nc(C(F)(F)F)cc3Cl)cc(=O)n2c1-c1cncnc1
Standard InChI: InChI=1S/C16H10ClF3N6OS/c1-8-14(9-4-21-7-22-5-9)26-13(27)2-10(23-15(26)28-8)6-25-12(17)3-11(24-25)16(18,19)20/h2-5,7H,6H2,1H3
Standard InChI Key: ZMXDMQPSSRDDMZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
2.2041 -10.6696 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.9141 -10.2663 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9176 -9.4491 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2110 -9.0352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2134 -8.2181 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.6195 -10.6788 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3295 -10.2742 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.0729 -10.6134 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6231 -10.0091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2185 -9.2991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4183 -9.4646 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.2369 -11.4139 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
5.5550 -8.5544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8567 -7.8764 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
6.3759 -8.3349 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
5.1695 -7.7897 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.5020 -10.2603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5055 -9.4466 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.7327 -9.1918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2516 -9.8481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7271 -10.5083 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
0.4836 -8.4135 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5735 -9.8446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0348 -7.8118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7862 -7.0341 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.0199 -6.8602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5674 -7.4700 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.3154 -8.2453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18 4 1 0
17 1 2 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
2 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 7 1 0
8 12 1 0
10 13 1 0
13 14 1 0
13 15 1 0
13 16 1 0
17 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 17 1 0
19 22 1 0
20 23 1 0
22 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 22 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 426.81Molecular Weight (Monoisotopic): 426.0277AlogP: 3.44#Rotatable Bonds: 3Polar Surface Area: 77.97Molecular Species: NEUTRALHBA: 8HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 1.01CX LogP: 2.20CX LogD: 2.20Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.50Np Likeness Score: -1.84
References 1. Villemure E, Volgraf M, Jiang Y, Wu G, Ly CQ, Yuen PW, Lu A, Luo X, Liu M, Zhang S, Lupardus PJ, Wallweber HJ, Liederer BM, Deshmukh G, Plise E, Tay S, Wang TM, Hanson JE, Hackos DH, Scearce-Levie K, Schwarz JB, Sellers BD.. (2017) GluN2A-Selective Pyridopyrimidinone Series of NMDAR Positive Allosteric Modulators with an Improved in Vivo Profile., 8 (1): [PMID:28105280 ] [10.1021/acsmedchemlett.6b00388 ]